Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients

PURPOSE: Neoadjuvant chemotherapy (NCT) is typically the initial treatment for non-early breast cancer patients. We thereby conducted a meta-analysis to explore whether dose-dense neoadjuvant chemotherapy (ddNCT) improved the long-term prognosis of patients compared to the standard NCT regimen. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yuqin, Ding, Kaijing, Yang, Hongjian, He, Xiangming, Mo, Wenju, Ding, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259732/
https://www.ncbi.nlm.nih.gov/pubmed/32470093
http://dx.doi.org/10.1371/journal.pone.0234058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259732/
https://www.ncbi.nlm.nih.gov/pubmed/32470093
http://dx.doi.org/10.1371/journal.pone.0234058

Ejemplares similares